Vascular News and Research

RSS

Mummies provide important twist in understanding atherosclerotic vascular disease

Like nearly 4.6 million Americans, ancient hunter-gatherers also suffered from clogged arteries, revealing that the plaque build-up causing blood clots, heart attacks and strokes is not just a result of fatty diets or couch potato habits, according to new research in the journal The Lancet.

11 Mar 2013

Inclacumab reduces damage to heart muscle during angioplasty

A single dose of an investigational anti-inflammatory drug called inclacumab considerably reduces damage to heart muscle during angioplasty (the opening of a blocked artery), according to a recent international clinical trial spearheaded by Dr. Jean-Claude Tardif, Director of the Research Centre at the Montreal Heart Institute, affiliated with the University of Montreal.

11 Mar 2013

Abbott announces data from MitraClip system study on mitral regurgitation

Abbott today announced data from the EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) High Surgical Risk cohort evaluating the company's first-in-class catheter-based MitraClip System for the treatment of mitral regurgitation (MR).

11 Mar 2013

Patients with PTSD more likely to develop insulin resistance, metabolic syndrome and heart disease

Patients diagnosed with post-traumatic stress disorder (PTSD) have a significantly higher risk of developing insulin resistance and metabolic syndrome, placing them at greater risk for heart disease and diabetes, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session. Researchers say public health interventions are urgently needed to prevent PTSD-related metabolic disorder at its early, reversible stage.

8 Mar 2013

Researchers explore genetic testing to identify people at high risk for preventable disease

In ten years time, routine preventive health care for adults may include genetic testing alongside the now familiar tests for cholesterol levels, mammography and colonoscopy.

8 Mar 2013

New Orleans residents continue to face increased risk of heart attack post-Katrina

New Orleans residents continue to face a three-fold increased risk of heart attack post-Katrina-a trend that has remained unchanged since the storm hit in 2005, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.

7 Mar 2013

High HDL levels block development of aneurysms in the aorta

New research provides early evidence that 'good' cholesterol may possess anti-aneurysm forming properties. In laboratory-based investigations, scientists found that increased levels of high-density lipoproteins (HDL), the so-called good cholesterol, blocked the development of aneurysms - dangerous 'ballooning' in the wall of a blood vessel - in the body's largest artery, the aorta.

7 Mar 2013

Study shows how fish oils help lower blood pressure via vasodilation at ion channels

Omega-3 fatty acids found in oily fish may have diverse health-promoting effects, potentially protecting the immune, nervous, and cardiovascular systems.

6 Mar 2013

Study distinguishes MRI from other techniques to assess myocardial viability

Researchers using cardiac magnetic resonance imaging (MRI) discovered that thinned non-contracting heart muscle caused by a heart attack can potentially improve in function and be reversed after cardiac bypass surgery.

6 Mar 2013

Hiring nurses with four-year degrees decreases patient deaths, new research report says

When hospitals hire more nurses with four-year degrees, patient deaths following common surgeries decrease, according to new research by the University of Pennsylvania School of Nursing's Center for Health Outcomes and Policy Research as reported in the March issue of the prestigious policy journal Health Affairs.

5 Mar 2013

tRNA synthetases play unexpected and critical role in cancer metastasis

Studied for decades for their essential role in making proteins within cells, several amino acids known as tRNA synthetases were recently found to have an unexpected - and critical - additional role in cancer metastasis in a study conducted collaboratively in the labs of Karen Lounsbury, Ph.D., University of Vermont professor of pharmacology, and Christopher Francklyn, Ph.D., UVM professor of biochemistry.

5 Mar 2013

Sanford Health announces new limb preservation program

Sanford Health announces a new limb preservation program, Sanford Limb Preservation Center. The center specializes in treating lower extremity wounds in patients at high risk of amputation and compromised leg and toe function, particularly those with diabetes and peripheral arterial disease.

5 Mar 2013

FDA approves Tenaxis Medical’s ArterX Surgical Sealant

Tenaxis Medical, Inc., a medical device company focused on the development of functionally designed surgical sealants has received FDA approval to bring its innovative ArterX Surgical Sealant to the market.

4 Mar 2013

CIS now offers Toshiba’s Aplio 500 cardiac ultrasound

Cardiovascular Institute of the South (CIS) now offers its patients the most advanced cardiac ultrasound, thanks to its purchase of 10 Aplio 500s from Toshiba America Medical Systems, Inc.

4 Mar 2013

Oraya Therapy safe and effective for patients with wet AMD

Oraya Therapeutics, Inc. today announced that one of the patients who successfully was treated for wet age-related macular degeneration (AMD) with Oraya Therapy during the INTREPID clinical trial has released data showing he has experienced significant, sustained vision improvement more than two years after treatment in his right eye, without any subsequent anti-vascular endothelial growth factor (anti-VEGF) injections or other treatment.

1 Mar 2013

Anti-LG3 associated with high rate of organ rejection during transplantation

A team led by Dr. Marie-Jos-e H-bert from the University of Montreal Hospital* Research Centre (CRCHUM) has discovered a new cause of organ rejection in some kidney transplant patients. Her team has identified a new class of antibodies - anti-LG3 - which when activated lead to severe rejection episodes associated with a high rate of organ loss.

28 Feb 2013

EpiCept fourth quarter revenue decreases to $0.1 million

EpiCept Corporation today announced operating and financial results for the fourth quarter and full year ended December 31, 2012, and provided an update on the Company's merger with Immune Pharmaceuticals, Ltd. (Immune).

28 Feb 2013

Surefire Medical’s latest line of infusion system and specialty catheters receive CE Mark approval

Surefire Medical, Inc., the developer of a new class of infusion systems designed to maximize targeted delivery of embolization agents without reflux, today announced CE Mark approval for its Surefire Infusion System ST/LT and Surefire Specialty Catheters.

26 Feb 2013

Henry Ford Hospital scientists to research into hypertension and tissue and organ damage

A senior staff scientist and his team at Henry Ford Hospital have been awarded a five-year, $12.4 million grant by the National Institutes of Health for their research into the damaging effects of high blood pressure on various organs in the body.

26 Feb 2013

CHADS scores possibilities extend beyond atrial fibrillation

The CHADS-based risk scores can predict long-term vascular outcomes and mortality in patients with stroke who do not have atrial fibrillation, research suggests.

25 Feb 2013

Vascular News and Research

Mummies provide important twist in understanding atherosclerotic vascular disease

Inclacumab reduces damage to heart muscle during angioplasty

Abbott announces data from MitraClip system study on mitral regurgitation

Patients with PTSD more likely to develop insulin resistance, metabolic syndrome and heart disease

Researchers explore genetic testing to identify people at high risk for preventable disease

New Orleans residents continue to face increased risk of heart attack post-Katrina

High HDL levels block development of aneurysms in the aorta

Study shows how fish oils help lower blood pressure via vasodilation at ion channels

Study distinguishes MRI from other techniques to assess myocardial viability

Hiring nurses with four-year degrees decreases patient deaths, new research report says

tRNA synthetases play unexpected and critical role in cancer metastasis

Sanford Health announces new limb preservation program

FDA approves Tenaxis Medical’s ArterX Surgical Sealant

CIS now offers Toshiba’s Aplio 500 cardiac ultrasound

Oraya Therapy safe and effective for patients with wet AMD

Anti-LG3 associated with high rate of organ rejection during transplantation

EpiCept fourth quarter revenue decreases to $0.1 million

Surefire Medical’s latest line of infusion system and specialty catheters receive CE Mark approval

Henry Ford Hospital scientists to research into hypertension and tissue and organ damage

CHADS scores possibilities extend beyond atrial fibrillation

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News